[ad_1]
Pharmaceutical organization Revealing the primary effects of cannabis treatment Good quality of life patient Tends to inhibit cancer cells Animal testing
Today (September 7, 2020) Nanthakan Suwanpitokkul Specialists The Government Pharmaceutical Organization (AD) revealed that the government distributed medicinal cannabis products to the medicinal cannabis service system through a research project. And medical marijuana clinics in various health care settings, both public and private.Since August 2019, the Police Department has continuously monitored the effectiveness of its use providing support to doctors who prescribe medical marijuana. It is used for effective diagnosis and treatment. And get the standard academic information and guidelines for the use of medical marijuana in Thailand.
Recently, the results of a study on the pharmacist’s use of medicinal cannabis products were reported
Dr. Nanthakan said that studies of diseases and conditions using medicinal cannabis products have been beneficial. By the Institute of Neurology and the Queen Sirikit National Institute of Children’s Health (Children’s Hospital) has monitored the effectiveness of the use of prominent GPO CBD cannabis products in patients with difficult-to-treat epilepsy. And 16 patients with intractable epilepsy. Results showed that she was able to control seizures in 10 patients, 62%, and caregivers’ evaluations thought their seizures improved. With an average grade score of 5-6 out of a total score of 7
Additionally, the Ph.D. Nanthakan said the Institute for Neuroscience has also monitored the effectiveness of GPO THC: CBD (1: 1) in treating muscle spasms in multiple sclerosis patients. Seven patients did not respond to standard therapy, five of whom were evaluated by physicians, which was consistent with the results of a patient evaluation that their spasms and pain improved after cannabis extract. The average satisfaction score is 5-6 out of 7 points.
“For palliative care, the National Cancer Institute is conducting a research program to monitor the safety and effectiveness of medical marijuana. To improve the quality of life of patients with advanced stage cancer, 14 patients participated in the program and received an average of 1-3 drops of GPO THC: CBD (1: 1) daily for 3 months. With symptoms (pain score) reduced by more than 50 percent from the beginning You have an increased appetite and weight gain. However, the use of medicinal cannabis extract to improve the quality of life of cancer patients should be closely monitored, Dr. Nanthakan said. As well as additional studies on the effectiveness and profitability of each state of the problem
Dr. Nanthakan said that in the study of Parkinson’s patients. It is classified as a potentially beneficial disease and condition. Sakon Nakhon Hospital has been monitoring treatment and safety outcomes in 16 Parkinson’s patients based on assessment of cognitive ability. Daily routine After three months of administration of GPO THC: CBD (1: 1), the patient improved. And, for the most part, they improve sleep and quality of life. No effect on the memory of the patient Although the results of the preliminary study are promising. But long-term studies on the use of cannabis extracts in Parkinson’s patients should be investigated.
Specialists The police officer went on to say In the treatment of cancer that it is a group of diseases and conditions that can be beneficial. The National Cancer Institute conducted research on the efficacy of cannabis extract against the growth of cancer cells in vitro using the medical marijuana extract from the Ph.D. found that THC and CBD had different effects on inhibiting cancer cells. together The combination of THC and CBD was also found likely to be beneficial in inhibiting breast, pancreas and bile duct cancer cells, which could potentially be tested in animal studies.
In addition, there is an effect of the medical marijuana clinic, the Department of Medical Service for the care of patients with end stage cancer, using GPO THC at a dose of 0.5-5 mg per day in conjunction with the drug used by the patient . An evaluation of 42 patients who completed one month of follow-up showed improvement in pain, loss of appetite, and insomnia. Low-dose THC has been shown to be safe and can improve quality of life in end-stage cancer patients. And the follow-up of the results of the use with patients who use the services of a medical marijuana clinic. From various sanatoriums including the Bamrasnaradura Institute, Srinakarin Hospital, Hat Yai Hospital, Sakon Nakhon Hospital, Phutthachinarat Hospital, Phitsanulok Province, and Orichin Clinic they found that the majority of patients responded well to treatment. No serious side effects were found. Common side effects are dry mouth, dry throat, confusion, dizziness, headache, palpitations, and nausea and vomiting.
“However, the results of the reported studies were only preliminary. It can be seen that the results of use go in a good direction, helping to reduce symptoms, in accordance with the research objectives and properties of the PhD product, which are yet to be be studied in a growing number of patients. And continuously monitor the effectiveness and safety of medical marijuana extract products. Medical grade or medical grade products that consider safety (safety) have an extract with the active ingredient of the drug on a regular basis. (Consistency) and efficiency (Efficacy), ”said Dr. Nanthakan.
[ad_2]
